ATE244008T1 - Verwendung von makroliden zur behandlung von akuten lungenverletzungen - Google Patents

Verwendung von makroliden zur behandlung von akuten lungenverletzungen

Info

Publication number
ATE244008T1
ATE244008T1 AT99937870T AT99937870T ATE244008T1 AT E244008 T1 ATE244008 T1 AT E244008T1 AT 99937870 T AT99937870 T AT 99937870T AT 99937870 T AT99937870 T AT 99937870T AT E244008 T1 ATE244008 T1 AT E244008T1
Authority
AT
Austria
Prior art keywords
macrolids
lung injury
acute lung
treat acute
compounds
Prior art date
Application number
AT99937870T
Other languages
English (en)
Inventor
Tadatsura Koshika
Itsuo Nagatomi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE244008T1 publication Critical patent/ATE244008T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT99937870T 1998-03-06 1999-03-04 Verwendung von makroliden zur behandlung von akuten lungenverletzungen ATE244008T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP2231A AUPP223198A0 (en) 1998-03-06 1998-03-06 New use
PCT/JP1999/001064 WO1999044597A2 (en) 1998-03-06 1999-03-04 Use of macrolide compounds for the treatment of ards

Publications (1)

Publication Number Publication Date
ATE244008T1 true ATE244008T1 (de) 2003-07-15

Family

ID=3806495

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99937870T ATE244008T1 (de) 1998-03-06 1999-03-04 Verwendung von makroliden zur behandlung von akuten lungenverletzungen

Country Status (14)

Country Link
US (1) US6333334B1 (de)
EP (1) EP1059921B1 (de)
JP (1) JP3367105B2 (de)
KR (1) KR100395571B1 (de)
CN (1) CN1133429C (de)
AT (1) ATE244008T1 (de)
AU (1) AUPP223198A0 (de)
BR (1) BR9908796A (de)
CA (1) CA2322027C (de)
DE (1) DE69909257T2 (de)
DK (1) DK1059921T3 (de)
ES (1) ES2196840T3 (de)
PT (1) PT1059921E (de)
WO (1) WO1999044597A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
SI2071917T1 (sl) * 2006-09-29 2013-03-29 Infa S.A. Pakirni sistem za farmacevtske sestavke in komplet za intravensko aplikacijo
EP2068865A4 (de) * 2006-12-28 2011-08-10 Limerick Biopharma Inc Verfahren und zusammensetzungen für therapiebehandlung
WO2008127746A1 (en) 2007-01-10 2008-10-23 Board Of Regents The University Of Texas System Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
CN101011414B (zh) * 2007-01-29 2010-07-21 褚福明 一种肺脑合剂药物
CA2693338A1 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Phosphorylated pyrone analogs and methods
CN101810633B (zh) * 2010-03-31 2011-12-14 湖北丝宝药业有限公司 地红霉素在制备治疗慢性非感染性呼吸道疾病药物的用途
GB201212773D0 (en) * 2012-07-18 2012-08-29 Ucl Business Plc Vascular remodelling
MX2022014958A (es) * 2020-05-28 2023-04-13 Phor Med Inc Composiciones y métodos para tratar el síndrome de dificultad respiratoria aguda (sdra) y trastornos inflamatorios provocados por coronavirus y otros patógenos respiratorios o agentes que median en la lesión pulmonar, inflamación dificultad respiratoria aguda, asi como composiciones y métodos relacionados para tratar y prevenir la infección por coronavirus sars en humanos, la enfermedad por covid-19 y síntomas relacionados.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
GB2248184A (en) * 1990-09-28 1992-04-01 Fujisawa Pharmaceutical Co New use of macrolide compounds for active oxygen-mediated diseases
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
AU8910891A (en) * 1990-11-20 1992-06-11 National Heart & Lung Institute, The Treatment of lung diseases
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5290689A (en) * 1992-09-28 1994-03-01 Merck & Co., Inc. New cyclic FR-900520 microbial biotransformation agent

Also Published As

Publication number Publication date
ES2196840T3 (es) 2003-12-16
CN1133429C (zh) 2004-01-07
JP3367105B2 (ja) 2003-01-14
PT1059921E (pt) 2003-11-28
US6333334B1 (en) 2001-12-25
DE69909257T2 (de) 2004-02-19
JP2001520682A (ja) 2001-10-30
CA2322027A1 (en) 1999-09-10
DE69909257D1 (de) 2003-08-07
AUPP223198A0 (en) 1998-04-02
KR100395571B1 (ko) 2003-08-21
WO1999044597A2 (en) 1999-09-10
BR9908796A (pt) 2000-10-31
CA2322027C (en) 2009-05-12
KR20010041046A (ko) 2001-05-15
CN1292695A (zh) 2001-04-25
HK1036406A1 (en) 2002-01-04
WO1999044597A3 (en) 1999-12-29
EP1059921B1 (de) 2003-07-02
DK1059921T3 (da) 2003-10-27
EP1059921A2 (de) 2000-12-20

Similar Documents

Publication Publication Date Title
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
DE69726245D1 (de) Befeuchtungsgerät zur Behandlung von Atemstillstand im Schlaf
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
ATE251903T1 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
DE69916686D1 (de) Gerät zur Behandlung von Atemstillstand im Schlaf
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE60017801D1 (de) Inhalierung von antiendotoxinmitteln zur vorbeugung oder behandlung von bakterieller lungeninfektion oder symptomatischer endotoxinaussetzung der lunge
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
DE69909257D1 (de) Verwendung von makroliden zur behandlung von akuten lungenverletzungen
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE69914951D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE264309T1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE60034110D1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DE69504717D1 (de) Behandlung von organischen Verbindungen zur Reduzierung des Chlorgehaltes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1059921

Country of ref document: EP

REN Ceased due to non-payment of the annual fee